SCHEMBL22949665

SCHEMBL22949665

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4ccc5c(c4)S(c4ccc6ccccc6c4)(c4ccc6ccccc6c4)c4ccccc4-5)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
MAPT P10636 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
ADORA2B P29275 1/20 0.33
HPGD P15428 1/20 0.33
DHFR P00374 1/20 0.32
GSTP1 P09211 1/20 0.32
MET P08581 1/20 0.31
HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949612 0.99 MEN1 (0.39) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22949326 0.94 MEN1 (0.40) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22949681 0.94 MEN1 (0.40) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22949537 0.94 MEN1 (0.40) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22949027 0.92 MEN1 (0.41) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22947480 0.89 MEN1 (0.36) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22949598 0.87 MEN1 (0.37) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22947517 0.85 NPC1 (0.39) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22948687 0.84 ALDH1A1 (0.39) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL22949682 0.84 NPC1 (0.40) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885SMN1; SMN2 3681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.